InvestorsObserver
×
News Home

Should You Buy Greenlane Holdings Inc (GNLN) in Pharmaceutical Retailers Industry?

Tuesday, October 20, 2020 08:40 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Greenlane Holdings Inc (GNLN) in Pharmaceutical Retailers Industry?

Greenlane Holdings Inc (GNLN) is the highest overall rated company in the Pharmaceutical Retailers industry with an overall score of 57. GNLN is down -14.73% so far this year after the company closed yesterday at $3.01. The overall score measures the company's performance based-off both short and long term indicators and means that GNLN scores better than 57% of the overall market.

Overall Score - 57
GNLN has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on GNLN!

Greenlane Holdings Inc is a strong performer in the Pharmaceutical Retailers industry, which has an average overall score of 27. This means that, on average, the stocks in this industry score higher than 27% of the stock market.

To see InvestorsObserver's Sentiment Score for Greenlane Holdings Inc click here.

GNLN has been trading bullishly recently. The stock is trading up 1.01% this week following yesterday's decline. GNLN has an average analyst ranking of Strong Buy with an average price target of $5.75.

Click Here to get the full Stock Score Report on Greenlane Holdings Inc (GNLN) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App